Safety, efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide (exendin 9-39) for treatment of post-bariatric hypoglycaemia
During this phase: Inject your GLP-1 on a consistent schedule Eat smaller, lighter meals to reduce nausea Stay hydrated (dehydration worsens GI side effects) Track your appetite, energy levels, and any side effects Don't add Ipamorelin yet The reason for starting with only the GLP-1 is straightforward
These include the lower abdomen, flanks (love handles), inner and outer thighs, upper arms, and the submental area under the chin
Then, articles were scanned and the data from these studies was extracted, including the number of patients per arm, L-carnitine dosing (including initial loading dosing and daily oral maintenance dosing), acute MI (AMI) index event type, follow-up duration, and outcomes (i.e., all-cause mortality, adverse cardiovascular events including unstable angina, acute MI, heart failure, and ventricular arrythmia)